Cigna Group

CI has broken below its consolidation support with a terminal Support Failure pattern, accelerating below the 9- and 21-day EMAs. The high Stage Transition Risk and lack of short-term exhaustion invalidate the prior bullish posture, shifting the medium-term bias to bearish. Execution should be deferred until a retest of the broken support/EMA zone offers a clean rejection setup for trimming the position.

• ↑Q1 revenue $68.5B (+9% YoY) and adjusted EPS $7.79 (+16%)
• ↑Raised full-year adjusted EPS guidance to at least $30.35
• ↓Negative profitability score flags margin risk in pharmacy benefit services